- Pharmaceutical Research Development | AbbVie
AbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's lives
- Patient Assistance | AbbVie
AbbVie is committed to helping patients get the medicines they need That’s why we offer patient assistance programs that provide free AbbVie medicines to qualifying patients
- AbbVie Inc. (ABBV) Stock Price, News, Quote History - Yahoo . . .
Find the latest AbbVie Inc (ABBV) stock quote, history, news and other vital information to help you with your stock trading and investing
- About AbbVie - Our Company | AbbVie
When we became our own company, AbbVie formed a new kind of enterprise—a biopharmaceutical company We blend the stability, global scale, resources and commercial capabilities of a pharmaceutical company with the focus and culture of a biotech
- AbbVie to Acquire Capstan Therapeutics, Further Strengthening . . .
AbbVie to Acquire Capstan Therapeutics, Further Strengthening Commitment to Transforming Patient Care in Immunology Capstan's lead asset, CPTX2309, is a targeted lipid nanoparticle (tLNP) that delivers an mRNA encoding an anti-CD19 chimeric antigen receptor (CAR) to CD8-expressing cytotoxic T cells in vivo, and is a potential first-in-class
- Investor Overview | AbbVie
AbbVie discovers, develops, and commercializes advanced therapies that have an impact on people's lives Today, our passionate AbbVie team has approximately ~50,000 employees working together to help patients around the world
- AbbVie to buy Capstan Therapeutics - CNBC
AbbVie has been diversifying its portfolio to make up for a steep decline in sales of Humira, its rheumatoid arthritis drug that is facing stiff competition
- AbbVie - Wikipedia
AbbVie Inc is an American pharmaceutical company headquartered in North Chicago, Illinois
|